Medical

Third-party Maintenance Providers: An Unfulfilled Potential for Patients and Paymasters

Diagnostic Medical Imaging (DI) is part of the broader market of “medical devices”. It has revolutionised healthcare over the years by enabling doctors, specifically radiologists, to diagnose diseases early, and with certainty. Equipment is typically divided into complex high-end machines such as CT and MRI scanners, and technically simpler devices such as ultrasound scanners. These DI devices enable physicians to non-invasively diagnose disease and manage therapy.

Read more about what IAMERS had to say here.

Novel MRI technique could offer new avenue for Alzheimer’s, stroke risk assessment

A new MRI scanning technique being investigated in Toronto could one day help physicians identify patients on the path to developing Alzheimer’s disease, and do so at a cost far less than molecular imaging of amyloid deposits, according to an in-depth profile of the project published by theToronto Star.

Read more here.

Before the Deluge: What Changing Demographics Mean for Imaging

Age catches up with us all at some point. For the Baby Boomers, that point is arriving year after year, with 10,000 Americans turning 65 every day from now until 2030. It’s no secret our elderly population will grow to levels never before seen in the U.S. Meanwhile, the obesity epidemic rages on and other macroeconomic forces, such as the recovering economy and widespread health policy reforms, also promise to change the equation in healthcare. Are we prepared?

Read more here.

SHINE Medical Technologies To Supply Moly-99 To GE Healthcare

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that it has entered into a strategic long-term supply agreement with GE Healthcare, a division of the General Electric Company, for supply of molybdenum-99 (moly-99). This is the first announcement of a major supply agreement with a U.S. based producer of moly-99. Moly-99 decays into the diagnostic imaging agent technetium-99m (Tc-99m).  Tc‑99m’s extraordinary attributes make it the most commonly-used medical isotope on the planet (used in over 40 million medical imaging procedures per year). Under the terms of the supply agreement, SHINE will provide moly-99 to GE Healthcare on a regular basis once its facility becomes operational.

Read more here.

Page 1 of 612345...Last »